Hello sir, Can you explain how can we plan SIP method in this strategy. Thank you
Posts in category Value Pickr
Valuing the S&P BSE SENSEX: All is Fair in Love and Markets (27-07-2024)
(post deleted by author)
Glenmark Life Sciences (27-07-2024)
In Concall GLS Management stated that they are confident that matter will be resolved shortly and in next 2 months of this quater they will makeup the production loss. Indirectly they are trying to say that by this month end matter will be resolved.
Gujarat Themis Biosyn Ltd – Bulk Drugs growth momentum (26-07-2024)
Thanks for the update. Management should hold a conference to give clarity in the capex and newer products. Quant MF entered the stock , so was expecting the 200cr capex revenue kickstarting
Pyramid Technoplast – Chota Time technolpast (26-07-2024)
well written considering you have looked at all angles. I have also taken position , will keep an eye on the execution
Pyramid Technoplast – Chota Time technolpast (26-07-2024)
well written considering you have looked at all angles. I have also taken position , will keep an eye on the execution
Coastal Corp. ~2.5x capacity exp. 4x profits? Downcycle a risk (26-07-2024)
Its interesting, could you please share the source of the data.
Coastal Corp. ~2.5x capacity exp. 4x profits? Downcycle a risk (26-07-2024)
Its interesting, could you please share the source of the data.
Omkar’s Portfolio Analysis and Discussion (26-07-2024)
Current portfolio
Company | % |
---|---|
Suprajit Eng | 23.00% |
Ajanta Pharma | 18.50% |
Kotak Bank | 5.75% |
Vinati Org | 4.24% |
Abbott India | 2.95% |
ICICI Bank | 2.90% |
HDFC Bank | 2.88% |
Bajaj Finserv | 2.53% |
HCL Tech | 2.51% |
Mutuals funds | 35% |
Omkar’s Portfolio Analysis and Discussion (26-07-2024)
Why I will keep Holding Kotak ( and HDFC/ICICI/Bajaj Finserv ) despite lacklustre Q1 FY25
Though equity market has derated private banks in last 3-4 years, as per my judgement there is no change in the strength of their franchise which according me lies in –
- Diversified financial conglomerates with stable low ROE annuity flow to balance high ROE but volatile capital market revenue streams
- Proven underwriting which allows to take large allocations with buying points spread across current cycle to benefit multiple future cycles
As my execution style gives least importance to near term earnings, I am happy to hold or even add my investments as long has franchise’s earning power is not lost